STAT questions Lilly's obesity drug access granted to 79-year-old patient
The report examines an unusual individual access arrangement for a Lilly obesity medicine and who the recipient was.
MH
By Maren Holt · Senior Reporter, GLP-1
Jun 23 03:00 ETSource: statnews.com
The wire
- 01STAT reports Eli Lilly provided what it describes as extraordinary access to an obesity drug for a 79-year-old patient.
- 02Individual access arrangements outside normal channels raise equity and expanded-access questions for clinicians fielding patient requests.
- 03The identity of the patient and the terms of the arrangement remain the central open questions in the report.
From the source
Read at statnews.comEli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?